Noom Launches Free Version of Its Powerful GLP-1 Companion Empowering Providers with a Research-Backed Tool to Support Weight Loss That Lasts Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off for good PRINCETON, N.J., June 24, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company trusted by millions, today announced the launch of its free GLP-1 Companion program, now available at no cost to anyone taking a GLP-1 medication, regardless of provider
Researchers studying the small opioid peptide met-enkephalin (then known to have something to do with pain relief) released something interesting
corpus callosum in CAE), in the former, a deliberately orchestrated primary autoimmune process directed at myelin antigens results in lymphocytic infiltration, secondary injury to white matter and a universal innate response, whereas in CAE, where the primary insult is a biochemical one deliberately targeting intrinsic CNS myelin, following immune stimulation, the resulting lesion is pathologically similar (Day, 2005
Strong responsible-play toolingdeposit limits, cooling-off periods, and self-exclusionsignals a sustainable approach that respects player wellbeing